On 15 April 2026, Alzheimer Europe and the Alzheimer Europe Foundation announced that applications are open for the 2026 edition of their Anti-Stigma Award. This year, the Award will recognise a European artist or initiative using music to address the stigma surrounding dementia, contributing to a positive image of dementia and of people living with dementia.
Our Anti-Stigma Award has continued to grow in scope and reach since its beginnings in 2022, and we are delighted to welcome applications fitting this year’s theme of music and dementia, from artists or initiatives established in a member country of Alzheimer Europe. Applications can be submitted by the artist or initiative directly, or by a nominating member association of Alzheimer Europe. In the latter case, the written consent of the nominated artist or initiative must be sought prior to making the application on their behalf. Submitted works must have been produced in the past three years (2023-2026) to be eligible for the Award.
The Award consists of a cash prize of EUR 5,000 for first place, a cash prize of EUR 2,500 for second place and a cash prize of EUR 1,250 for third place, each of which will be accompanied by a trophy. The winners will be announced during a special Award Ceremony and Networking Dinner on 28 October 2026 in Dublin (Ireland).
Interested artists, initiatives or national Alzheimer’s associations wishing to nominate someone, should send in the completed application form by the deadline of 26 June 2026.
Applicants may be short listed and asked to present their work to the members of the Award Committee at an online meeting on 13 July. Travel and accommodation costs for the top three applicants will be covered by Alzheimer Europe, to attend the award ceremony in Dublin on 28 October.
More information, as well as the application form, can be found at: https://www.alzheimer-europe.org/anti-stigma-award-2026
Alzheimer Europe gratefully acknowledges the support of the sponsors of the Alzheimer Europe Anti-Stigma Award: Alzheimer Europe Foundation, Lilly and Roche.
